| 注册
首页|期刊导航|四川医学|培哚普利与缬沙坦联合运用对高血压合并蛋白尿的影响

培哚普利与缬沙坦联合运用对高血压合并蛋白尿的影响

陈俐

四川医学2012,Vol.33Issue(6):998-999,2.
四川医学2012,Vol.33Issue(6):998-999,2.

培哚普利与缬沙坦联合运用对高血压合并蛋白尿的影响

Combination of Vallarta and Perindopril in treating hypertension complicating proteinuria

陈俐1

作者信息

  • 1. 都江堰市医疗中心心血管内科,四川都江堰611830
  • 折叠

摘要

Abstract

To investgate the effect of combining of Valsartan and Perindopril in hypertensive patients with proteinuria. Methods 60 patients with hypertension complicating proteinuria were randomly assigned Vallarta group (A guoup) and combination of Vallarta and Perindopril group ( B group). Systolic blood pressure ( SBF) , diastolic blood pressure ( DBP), 24h urine protein (Pro) , Urinary albumin (mALB) , serum creatinine (Scr), glomerular filtration rate (GFR) were measured af-ter 6-months treatments. Results ①Compared to pre-treatmeant , SBP, DBP, Pro, mALB, Scr were significant decreased in both A and B groups (P < 0.05),GFR was significan higher (P < 0.05); ② Cpmpare with single medicine group after 6-months treatments, Pro, mALB,Scr, and GFR were more changed in the combination group,the difference was statically significant(P< 0.05). Conclusion The protection efficiency of Combination of Vallarta and Perindopril group is better than Vallarta in patients with hypertension complicating proteinuria.

关键词

缬沙坦/培哚普利/高血压病/蛋白尿

Key words

Vallarta/Perindopril/hypertension/proteinuria

分类

医药卫生

引用本文复制引用

陈俐..培哚普利与缬沙坦联合运用对高血压合并蛋白尿的影响[J].四川医学,2012,33(6):998-999,2.

四川医学

OACSTPCD

1004-0501

访问量0
|
下载量0
段落导航相关论文